Replies to post #266311 on NorthWest Biotherapeutics Inc (NWBO)

[sukus]

Photonic and all here, if DCVax vaccines work for solid tumors and that mechanism of actions had been validated over and over through advanced imaging, why can’t these vaccine also be applied to non solid tumor too? If there is a way either through new technique or something else to expose these young dendritic cells to those non solid tumors, why can’t this work? I know you and alphapuppy are oncologist so you probably know. Others can chime in too. Thx.

[beartrap12]

“That would be worth more than 100 billion. Every....solid....tumor...on...Earth”
That’s why I would like to see NWBO sell off rights to treat with DCVaxL for the specific cancer type each time it is approved for that cancer. I would like to see shareholders given X amount of money based on the potential patient pool., as well as funds to the company to develop the next drug trials.
I know we may have issues with the drug being used off-label, but perhaps that money could come back to the company.
I think this idea is a stretch, so perhaps a partnership for the next few years, followed by a merger when NWBO is worth as much as, say, Merck, $80 a share.
Just my thoughts. I would hate to see us sell out at $15 to $30 dollars when this treatment has so much potential.